Immunogen (NASDAQ: IMGN) announced the appointment of Richard J. Gregory, Ph.D., as Executive Vice President, Research and Chief Scientific Officer ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE